Research memoAMETEK, Inc. (AME) · NYSEMemo of October 18, 2026

AMETEK stock forecast

AMETEK’s weighted price is $225.56 in October 2029, with Bear at 27%, Base at 53% and Bull at 20%. AMETEK’s outlook hinges on turning acquisition-led growth into durable organic cash generation.

248.17
Share price today, USD
225.56 (-7%)
Weighted scenario, October 2029
2.9%
Real free cash flow yield
26.3x
P/E, next 12 months
Read the full AMETEK memoYour first report is free · no card
Every number traced to AMETEK's filings8 chapters · 15,833 words162 sources cited

Where could AMETEK's shares be by 2029?

It is $219.22 in October 2028, a loss of 11%. It is $225.56 in October 2029, a loss of 7%. The 2029 range is $137.52 to $335.32. Today’s price is $248.17.

Bear has 27%. Base has 53%, while bull has 20%. The table shows how operating results, dividends and valuation combine into those outcomes.

Share price in October 2029: our three scenarios (USD)Today 248.17137.52Bear · 27% · -43%228.99Base · 53% · -6%335.32Bull · 20% · +37%
What the shares could be worthUSD per share at each date; in brackets the return since today's 248.17, dividends included
CaseProbabilityOctober 2027October 2028October 2029
Bear27%160.61 (-35%)147.62 (-39%)137.52 (-43%)
Base53%220.04 (-11%)225.94 (-8%)228.99 (-6%)
Bull20%260.68 (+6%)298.08 (+21%)335.32 (+37%)
Weighted100%212.12 (-14%)219.22 (-11%)225.56 (-7%)

What has to go right for AMETEK, and what could go wrong?

The base revenue assumptions are $8,600 million in 2027 and $9,000 million in 2028, reaching $9,450 million. Its margins are 20.2% initially and 20.5% thereafter. The bear case uses $8,200 million and $8,300 million, reaching $8,500 million, with margins falling from 18.7% to 18.5%. The bull case uses $8,800 million and $9,500 million, reaching $10,200 million, while margins expand from 20.5% to 21.3%. The bear reflects slower backlog conversion, interest and integration costs; the bull requires rapid synergies and debt reduction. The disclosed $17.8 million of integration costs is treated as non-recurring.

The bear case requires the recent order surge to fade, backlog to convert slowly and Indicor’s financing and integration costs to persist. Earnings weaken, margins stay near 18.5%, buybacks remain limited and investors pay less for each dollar of earnings.

How much cash does AMETEK really make?

AMETEK converts much of its accounting profit into cash, but not all of that cash is available to owners. Operating cash flow reflects collections, payments and non-cash accounting items; free cash flow subtracts spending on equipment and facilities.

Follow the money: real free cash flowUS$ thousands
20252024202320222021
Cash from operations1,801,7631,828,8481,735,2961,149,3731,160,457
− Capital spending130,248127,075136,249139,005110,671
= Free cash flow1,671,5151,701,7731,599,0471,010,3681,049,786
− Stock pay47,76747,86346,19947,37546,103
= Real free cash flow1,623,7481,653,9101,552,848962,9931,003,683
Real free cash flow, % of revenue21.9%23.8%23.5%15.7%18.1%

What this means. The company's free cash flow is only slightly different from ours because it rounded the same figures when reporting them.

What does an investor pay for AMETEK today?

What an investor pays todayUS$ thousands
Today (Oct 18, 2026)
Share price248.17
P/E, last 12 months (calculated)36.3x
P/E, next 12 months (calculated)26.3x
Free cash flow yield (calculated)2.9%
Real free cash flow yield (calculated)2.9%

What this means. The enterprise value is based on debt and cash from before the Indicor acquisition, so it may not show what the whole business is worth today.

From the full memo · 1. The business

AMETEK sells the tools and components that let other businesses measure, control, repair and build things. Its dollar begins with a factory, airline, laboratory or equipment maker and ends, after materials, labor and operating costs, as earnings and cash.

Continue reading, free
Your first report is free · no card

Where these numbers come from

More on AMETEK

AMETEK dividendAMETEK earnings

Its rivals

Parker (PH)Eaton (ETN)Emerson (EMR)Danaher (DHR)

Browse

All stocksS&P 500 companiesCompanies A
The full AMETEK memoYour first report is free
Read it